163 related articles for article (PubMed ID: 31730895)
1. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2.
Zhu X; Zhang T; Zhang Y; Chen H; Shen J; Jin X; Wei J; Zhang E; Xiao M; Fan Y; Mao R; Zhou G
Cell Signal; 2020 Feb; 66():109470. PubMed ID: 31730895
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
3. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
[TBL] [Abstract][Full Text] [Related]
4. Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.
Bai M; Wang P; Yang J; Zuo M; Ba Y
J Physiol Biochem; 2020 Nov; 76(4):549-560. PubMed ID: 32737704
[TBL] [Abstract][Full Text] [Related]
5. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
6. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract][Full Text] [Related]
7. TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.
Nyati S; Gregg BS; Xu J; Young G; Kimmel L; Nyati MK; Ray D; Speers C; Rehemtulla A
Neoplasia; 2020 Apr; 22(4):163-178. PubMed ID: 32143140
[TBL] [Abstract][Full Text] [Related]
8. A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.
Zhang J; Han C; Ungerleider N; Chen W; Song K; Wang Y; Kwon H; Ma W; Wu T
Hepatology; 2019 Apr; 69(4):1549-1563. PubMed ID: 30014520
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.
Zhou H; Wu G; Ma X; Xiao J; Yu G; Yang C; Xu N; Zhang B; Zhou J; Ye Z; Wang Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):89. PubMed ID: 29699590
[TBL] [Abstract][Full Text] [Related]
10. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
12. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis.
Du X; Pan Z; Li Q; Liu H; Li Q
Cell Death Dis; 2018 Feb; 9(2):151. PubMed ID: 29396446
[TBL] [Abstract][Full Text] [Related]
13. miR-122-5p negatively regulates the transforming growth factor-β/Smad signaling pathway in skeletal muscle myogenesis.
Ding Z; Lin J; Sun Y; Cong S; Liu S; Zhang Y; Chen Q; Chen J
Cell Biochem Funct; 2020 Mar; 38(2):231-238. PubMed ID: 31710120
[TBL] [Abstract][Full Text] [Related]
14. miR-1306 Mediates the Feedback Regulation of the TGF-β/SMAD Signaling Pathway in Granulosa Cells.
Yang L; Du X; Liu L; Cao Q; Pan Z; Li Q
Cells; 2019 Mar; 8(4):. PubMed ID: 30935128
[TBL] [Abstract][Full Text] [Related]
15. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
17. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
18. A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression.
Dutta RK; Chinnapaiyan S; Rasmussen L; Raju SV; Unwalla HJ
Mol Ther; 2019 Feb; 27(2):442-455. PubMed ID: 30595527
[TBL] [Abstract][Full Text] [Related]
19. Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.
Ni N; Fang X; Li Q
Sci Rep; 2021 Apr; 11(1):9294. PubMed ID: 33927274
[TBL] [Abstract][Full Text] [Related]
20. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
Zhou B; Guo W; Sun C; Zhang B; Zheng F
Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
